Wedbush Forecasts Geron’s Q2 Earnings (NASDAQ:GERN)
Geron Co. (NASDAQ:GERN – Free Report) – Equities researchers at Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for Geron in a research note issued on Wednesday, May 7th. Wedbush analyst R. Driscoll now anticipates that the biopharmaceutical company will post earnings of ($0.02) per share for the quarter, up from their prior […]
Geron Co. (NASDAQ:GERN – Free Report) – Equities researchers at Wedbush boosted their Q2 2025 earnings per share (EPS) estimates for Geron in a research note issued on Wednesday, May 7th. Wedbush analyst R. Driscoll now anticipates that the biopharmaceutical company will post earnings of ($0.02) per share for the quarter, up from their prior […]
